Multidisciplinary Association for Psychedelic Studies (MAPS)

The Multidisciplinary Association for Psychedelic Studies (MAPS) is a nonprofit organization focused on researching the therapeutic potential of psychedelic substances, such as MDMA and psilocybin. Founded in 1986, MAPS aims to develop and promote evidence-based treatments for mental health issues like PTSD and depression through psychedelic-assisted therapies. The organization supports clinical trials, advocates for regulatory changes, and educates the public and professionals about the benefits and risks of psychedelics. MAPS strives to enhance understanding and acceptance of psychedelics in the medical community and society at large.